(ROCK). Clinical trials have found that inhibition of the ROCK pathway contributes to the cardiovascular benefits of
therapy. Furthermore, ROCK inhibitors may have clinical applications for anti-
, and tumor metastasis inhibition.
More recently they have been studied for the treatment of glaucoma.
This page was last edited on 10 September 2017, at 06:18.
under CC BY-SA license.